AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States

Provided By PR Newswire

Last update: Dec 12, 2023

Use of CRRT increased during COVID and remained at these higher utilization levels

Study results demonstrate challenges physicians have with heparin and citrate, the two currently available CRRT anticoagulants